Ars Pharmaceuticals, Inc. (SPRY) — 10-Q/A Filings
All 10-Q/A filings from Ars Pharmaceuticals, Inc.. Browse 1 Amended Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q/A Filings (1)
-
ARS Pharma Files Q3 2024 10-Q/A Amendment
— Dec 6, 2024 Risk: low
ARS Pharmaceuticals, Inc. filed an amendment (10-Q/A) on December 6, 2024, for the quarterly period ending September 30, 2024. The company, formerly Silverback
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX